Navigation Links
Dendreon Announces Webcast Presentation at BIO CEO & Investor Conference
Date:2/7/2008

SEATTLE, Feb. 7 /PRNewswire-FirstCall/ -- Dendreon Corporation (Nasdaq: DNDN) today announced that Mitchell H. Gold, M.D., chairman and chief executive officer of Dendreon, will present a company update at the 10th Annual BIO CEO & Investor Conference in New York City, on Wednesday, February 13, 2008 at 1:15 p.m. ET.

A live audio webcast of the presentation will be accessible through the Investor Relations section of the Dendreon website, http://www.dendreon.com. If you are unable to listen to the live webcast, it will be archived on the site following the presentation. To access the replay, go to the Investor Relations section of the website.

Dendreon Corporation is a biotechnology company whose mission is to target cancer and transform lives through the discovery, development and commercialization of novel therapeutics that harness the immune system to fight cancer. The Company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy product candidates designed to stimulate an immune response. Active cellular immunotherapy holds promise because it may provide patients with a meaningful clinical benefit, such as survival, combined with low toxicity. The Company has its headquarters in Seattle, Washington and is traded on the Nasdaq Global Market under the symbol DNDN. For more information about the Company and its programs, visit http://www.dendreon.com.


'/>"/>
SOURCE Dendreon Corporation
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1

Related biology technology :

1. Dendreon Promotes Dr. Mark Frohlich to Senior Vice President of Clinical Affairs and Chief Medical Officer
2. Dendreon Reports Third Quarter 2007 Financial Results
3. Dendreon Announces Webcast Presentations at Upcoming Investor Conferences
4. Dendreon Secures $130 Million Committed Equity Financing Facility
5. Dendreon Announces Webcast Presentation at UBS Life Sciences Conference
6. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
7. VIRxSYS Announces Interim Results from VRX496 Gene Therapy Phase II Trial
8. Exelixis Announces February 12 Webcast of Presentation at the 10th Annual BIO CEO and Investor Conference
9. Global Probiotics Council Announces Young Investigator Grant for Probiotics Research to Fund the Next Generation of Gut Microbiota Research
10. Shengtai Pharmaceutical, Inc. Announces Conference Call to Discuss Second Quarter Results of Fiscal Year 2008
11. Meditrina Pharmaceuticals, Inc. Announces Exclusive Global License Agreement With AstraZeneca

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)..., QUINCY, Mass., Nov. 6 Myriant...iotech developer and manufacturer of renewable bi...referred technology provider Uhde GmbH, one of the..."Uhde"), announced an alliance for the engineering...s biobased Succinic Acid plants based on renewable...
(Date:11/6/2009)..., SAN MATEO, Calif., Nov. 6 /PRNewswire-FirstCa... Completed transfer of Qutenza(TM) E.U. Marketing...de significant progress in commercial readiness ac...ales; Senior Director, Marketing; and Director, Co... to board as director and Audit Committee chairman...
(Date:11/6/2009)..., CALGARY, Nov. 6 /PRNewswire-FirstCall/ - Onco...ytics" or the "Company") today announced updated r...IN(R) in patients with sarcomas metastatic to the ...onnective Tissue Oncology Society Meeting held in ...e poster presentation, entitled "A Phase II Study ...
(Date:11/6/2009)... The agenda for Arrowhead&...nference, which is set to take place on February 2... this three day conference we will highlight key i...speakers to share their experiences. , ...2009 -- The agenda for Arrowhead’s 2010 Per...
Breaking Biology Technology:Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 3NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3
...rchTechnology,Inc. (eRT), (Nasdaq: ERES ), a lead...ECG) collection and interpretation services,announ...ter results for the,period ended March 31, 2008 on... the release, the Company will host a conference c...ence call interested participants should dial,800-...
... Therapeutics,Inc. (Nasdaq: IMRX ) today announce...t Laboratories pursuant to which it has satisfied ... promissory note with Abbott issued in,connection ...ll title to,the urokinase assets, including the re...ory and clinical documentation, validated cell lin...
...hering-Plough,Corporation (NYSE: SGP ) today anno...cts from 12 product franchises in Europe. These ag...th by the European Commission as part,of its Octob... of the,Intervet animal health business from Akzo ...d Virbac, a French animal health,company, will acq...
Other Biology Technology:eResearchTechnology, Inc. to Announce 2008 First Quarter Results on May 5, 2008 2ImaRx Therapeutics Satisfies Abbott Note Obligation Associated With the Acquisition of Urokinase 2ImaRx Therapeutics Satisfies Abbott Note Obligation Associated With the Acquisition of Urokinase 3Schering-Plough Announces Planned Divestiture of Select Animal Health Products in Europe 2
(Date:11/9/2009)...arge blooms of tiny marine plants called phytoplan...xposed by the recent and rapid melting of ice shel...his remarkable colonisation is having a beneficial...phytoplankton sinks to the sea-bed where it can st... Reporting this week in the journal Global Chang...
(Date:11/9/2009)...he Springer journal Naturwissenschaften is publi...Darwin and Modern Biology" to commemorate Darwin,s...years ago in November 1859. Guest editor and autho...fessor of plant physiology and evolutionary biolog...cles in this special issue are available free of c...
(Date:11/9/2009)... A chemical culprit responsible for the rapid, mys...ic Ocean has been found by collaborating scientist...raphic Institution (WHOI). This same chemical may...he team discovered a previously unknown lipid, or ... and killing Emiliania huxleyi , a phytoplankton ...
Breaking Biology News(10 mins):Antarctica glacier retreat creates new carbon dioxide store 2Newly discovered fat molecule: An undersea killer with an upside 2Newly discovered fat molecule: An undersea killer with an upside 3Newly discovered fat molecule: An undersea killer with an upside 4Mountain States Health Alliance Rolls Out TEDS Talent Management System 53028 1Mountain States Health Alliance Rolls Out TEDS Talent Management System 53028 2Mountain States Health Alliance Rolls Out TEDS Talent Management System 53028 3Mountain States Health Alliance Rolls Out TEDS Talent Management System 53028 4Mountain States Health Alliance Rolls Out TEDS Talent Management System 53028 5New survey report 3A Primary care emphasis included in workplace wellness programs 53025 1New survey report 3A Primary care emphasis included in workplace wellness programs 53025 2New survey report 3A Primary care emphasis included in workplace wellness programs 53025 3New survey report 3A Primary care emphasis included in workplace wellness programs 53025 4New survey report 3A Primary care emphasis included in workplace wellness programs 53025 5This Summer is an Ideal Time for Commercial Real Estate Lease Renewal 53022 1This Summer is an Ideal Time for Commercial Real Estate Lease Renewal 53022 2This Summer is an Ideal Time for Commercial Real Estate Lease Renewal 53022 3
...ate change is the largest environmental change exp...ghts, storms and floods, which will undoubtedly le...icts in the areas migrated to. , In the aftermath...ina in the US, Rafael Reuveny from Indiana Univers...egradation on population migration, or ecomigratio...
...ING carbon dioxide deep below the earths surface c...lanets major contributors to climate change. , Un...tone, drained of oil by the energy giants, could p...udy found that sandstone reacts with injected flui...ctions are essential if the captured CO2 is not to...
...s release is also available in French . , Ecol... "pristine" ecosystems while ignoring the overwhel...esearchers from McGill University and the Universi...Erle Ellis of UMBC and Prof. Navin Ramankutty of M...g ecosystems into biomes (or "ecological communiti...
Other Biology News:Environmental exodus 2Planting carbon deep in the earth -- rather than the greenhouse 2Environmental researchers propose radical 'human-centric' map of the world 2
Rabbit Anti-Human DNase II Polyclonal Antibody, Unconjugated from Calbiochem
BD BioCoat Poly-D-Lysine 60 mm Culture Dishes from BD Biosciences - Discovery Labware
BD BioCoat Collagen I 60 mm Culture Dishes from BD Biosciences - Discovery Labware
Corning C ulture Dishes,100X20 mm,55Cm2,Sterile,6-Pack Carrier (6Pks Of 10 Dishes) from Sigma-Aldrich
Biology Products: